Skip to main content
Terug
OCS logo

Oculis Holding AG

Datakwaliteit: 100%
OCS
NASDAQ Healthcare Biotechnology
€ 24,60
▼ € 0,26 (-1,05%)
Marktkapitalisatie: 1,41B
Dagbereik
€ 24,46 € 25,96
52-Weeksbereik
€ 14,00 € 30,68
Volume
249.171
50D / 200D Gem.
€ 27,16 / € 21,03
Vorige Slotkoers
€ 24,86

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E -14,9 0,4
P/B 7,2 2,9
ROE % -70,1 3,8
Net Margin % 3,9
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Belangrijkste Punten

Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -62,51M
PEG of 0,60 suggests growth is underpriced

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-70,09%
ROIC-29,89%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,01
Current Ratio5,96
Interest Coverage-99,49

Waardering

P/E Ratio
-14,88
P/B Ratio7,16
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -100,00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -94,51M
ROE -70,09% ROA -40,01%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -62,51M
ROIC -29,89% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,01 Current Ratio 5,96
Interest Coverage -99,49 Dividend Yield 0,00%
Valuation
P/E Ratio -14,88 P/B Ratio 7,16
P/S Ratio N/A PEG Ratio 0,60
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,41B Enterprise Value 1,33B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 686.000,0 0,0 0,0 0,0
Net Income -94,51M -85,78M -88,80M -38,70M -18,55M
EPS (Diluted) -1,81 -2,12 -2,97 -1,18 -0,57
Gross Profit 0,0 -51,40M 0,0 0,0 0,0
Operating Income -79,15M -73,20M -80,71M -32,38M -13,23M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 236,23M 120,35M 114,35M 37,06M 58,04M
Total Liabilities 39,94M 46,97M 20,63M 135,05M 119,00M
Shareholders' Equity 196,29M 73,38M 93,73M -97,99M -60,96M
Total Debt 2,32M 1,18M 605.000,0 123,08M 114,27M
Cash & Equivalents 81,42M 27,71M 38,33M 19,79M 46,28M
Current Assets 219,14M 104,90M 101,02M 23,66M 47,98M
Current Liabilities 36,79M 44,24M 19,09M 12,02M 4,06M